Authors: Fischereder, M Luckow, B Hocher, B Wuthrich, RP Rothenpieler, U Schneeberger, H Panzer, U Stahl, RAK Hauser, IA Budde, K Neumayer, HH Kramer, BK Land, W Schlondorff, D

Citation: M. Fischereder et al., CC chemokine receptor 5 and renal-transplant survival, LANCET, 357(9270), 2001, pp. 1758-1761

Authors: Keunecke, C Rothenpieler, U Zanker, B Schneeberger, H Illner, WD Theodorakis, J Stangl, M Land, W

Citation: C. Keunecke et al., Mycophenolate mofetil monotherapy: An example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients, TRANSPLAN P, 32(1A), 2000, pp. 6S-8S

Authors: Zanker, B Rothenpieler, U Kubitza, A Schneeberger, H Hillebrand, G Land, W

Citation: B. Zanker et al., Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: A pilot study, TRANSPLAN P, 31(1-2), 1999, pp. 1142-1143